CERE - Cerevel Therapeutics Holdings Inc. (CERE) CEO Tony Coles on Q1 2021 Results - Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (CERE) Q1 2021 Results Earnings Conference Call May 17, 2021, 08:00 AM ET Company Participants Matt Calistri - Vice President, Investor Relations Tony Coles - Chairperson & Chief Executive Officer Abraham Ceesay - President Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Kathy Yi - Chief Financial Officer Conference Call Participants Paul Matteis - Stifel Michael Yee - Jefferies Greg Suvannavejh - Goldman Sachs Umer Raffat - Evercore Presentation Operator Good morning. Welcome to the Cerevel Therapeutics First Quarter 2021 Results - Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, you will have a opportunity to ask questions during the Q&A portion of the call. Please note that this call maybe recorded. I will now turn the call over to Matt Calistri, Vice President of Investor Relations. Matt Calistri Thank you. Good morning, everyone. We appreciate

For further details see:

Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2021 Results - Earnings Call Transcript